MBX Biosciences, Inc. (MBX)
63.85
+2.28
(+3.70%)
USD |
NASDAQ |
Sep 17, 16:00
63.85
0.00 (0.00%)
After-Hours: 20:00
MBX Biosciences Price : 63.85 for Sept. 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 61.34 | 62.75 | 59.49 | 61.57 | 1.160M |
| Sep 15, 2026 | 58.79 | 61.20 | 58.39 | 61.08 | 652593.0 |
| Sep 14, 2026 | 59.35 | 60.22 | 58.87 | 59.49 | 323679.0 |
| Sep 11, 2026 | 61.75 | 61.94 | 58.42 | 59.02 | 306208.0 |
| Sep 10, 2026 | 62.43 | 63.02 | 60.65 | 60.94 | 457267.0 |
| Sep 09, 2026 | 63.29 | 64.04 | 61.28 | 62.91 | 315690.0 |
| Sep 08, 2026 | 60.85 | 64.17 | 60.66 | 62.99 | 266221.0 |
| Sep 04, 2026 | 61.00 | 62.73 | 60.60 | 61.72 | 271775.0 |
| Sep 03, 2026 | 60.90 | 62.61 | 59.84 | 61.42 | 292658.0 |
| Sep 02, 2026 | 61.40 | 62.45 | 58.80 | 60.89 | 352286.0 |
| Sep 01, 2026 | 61.42 | 62.88 | 60.22 | 60.93 | 416086.0 |
| Aug 31, 2026 | 62.25 | 63.04 | 59.47 | 61.60 | 518300.0 |
| Aug 28, 2026 | 66.14 | 66.14 | 62.99 | 63.00 | 307655.0 |
| Aug 27, 2026 | 66.73 | 66.90 | 64.50 | 66.39 | 263545.0 |
| Aug 26, 2026 | 68.56 | 68.83 | 66.27 | 66.76 | 214779.0 |
| Aug 25, 2026 | 67.64 | 69.50 | 67.64 | 68.62 | 274033.0 |
| Aug 24, 2026 | 66.23 | 67.16 | 64.00 | 66.39 | 531065.0 |
| Aug 21, 2026 | 67.86 | 67.86 | 65.59 | 66.33 | 466649.0 |
| Aug 20, 2026 | 67.00 | 68.49 | 65.40 | 66.35 | 422511.0 |
| Aug 19, 2026 | 67.53 | 68.76 | 65.25 | 68.40 | 562345.0 |
| Aug 18, 2026 | 66.40 | 69.05 | 65.80 | 66.52 | 560737.0 |
| Aug 17, 2026 | 68.28 | 69.94 | 67.58 | 68.25 | 461171.0 |
| Aug 14, 2026 | 67.00 | 68.84 | 65.01 | 68.57 | 503142.0 |
| Aug 13, 2026 | 66.97 | 68.41 | 65.50 | 67.08 | 334917.0 |
| Aug 12, 2026 | 66.84 | 67.80 | 66.00 | 66.97 | 331488.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amylyx Pharmaceuticals, Inc. | 33.95 |
| ANI Pharmaceuticals, Inc. | 75.39 |
| Corcept Therapeutics, Inc. | 114.80 |
| Veru, Inc. | 2.40 |
| Johnson & Johnson | 270.91 |
Price Related Metrics
| PEG Ratio | -6.038 |
| Price to Book Value | 7.476 |
| Earnings Yield | -3.77% |
| Market Cap | 3.062B |
| PEGY Ratio | -6.038 |